United Therapeutics (UTHR) Assets (2009 - 2026)
United Therapeutics (UTHR) recorded Assets of $7.22 billion in Q2 2026, down 8.7% from $7.91 billion a year earlier but up 7.5% from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, United Therapeutics reported Assets of $7.88 billion, up 7.0% from FY2024.
- Annual Assets has increased for 11 straight years, with a five-year compound annual growth rate of 11.3% (FY2020 to FY2025).
- Across earlier years, Assets came in at $7.36 billion in FY2024 (+2.7%), $7.17 billion in FY2023 (+18.6%), $6.04 billion in FY2022 (+16.9%) and $5.17 billion in FY2021 (+12.0%).
- Quarterly Assets has ranged from $5.05 billion in Q3 2021 to $7.91 billion in Q2 2025 over the past five years.
- On a year-over-year basis, Assets rose in six of the last eight quarters, with growth averaging 3.7%.
- Peak year-over-year performance for Assets in the last five years was growth of 21.5% in Q3 2023, against a decline of 13.3% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $6.71 billion (Q1 2026), $7.88 billion (Q4 2025) and $7.35 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | United Therapeutics | 20.72 Bn | 10.22 Bn | 683.80 Mn | 7.22 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.22 Bn |
| Mar 31, 2026 | 6.71 Bn |
| Dec 31, 2025 | 7.88 Bn |
| Sep 30, 2025 | 7.35 Bn |
| Jun 30, 2025 | 7.91 Bn |
| Mar 31, 2025 | 7.74 Bn |
| Dec 31, 2024 | 7.36 Bn |
| Sep 30, 2024 | 7.12 Bn |
| Jun 30, 2024 | 6.72 Bn |
| Mar 31, 2024 | 6.50 Bn |
| Dec 31, 2023 | 7.17 Bn |
| Sep 30, 2023 | 7.02 Bn |
| Jun 30, 2023 | 6.68 Bn |
| Mar 31, 2023 | 6.35 Bn |
| Dec 31, 2022 | 6.04 Bn |
| Sep 30, 2022 | 5.78 Bn |
| Jun 30, 2022 | 5.54 Bn |
| Mar 31, 2022 | 5.36 Bn |
| Dec 31, 2021 | 5.17 Bn |
| Sep 30, 2021 | 5.05 Bn |
API Access
United Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();